Published in J Biol Chem on December 15, 1990
Regulation by proteolysis: energy-dependent proteases and their targets. Microbiol Rev (1992) 4.83
Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant. Mol Cell Biol (1994) 3.27
Yeast RAD6 encoded ubiquitin conjugating enzyme mediates protein degradation dependent on the N-end-recognizing E3 enzyme. EMBO J (1991) 1.80
A general requirement for the Sin3-Rpd3 histone deacetylase complex in regulating silencing in Saccharomyces cerevisiae. Genetics (1999) 1.70
The ubiquitin-conjugating enzyme Rad6 (Ubc2) is required for silencing in Saccharomyces cerevisiae. Mol Cell Biol (1997) 1.63
A ubiquitin-conjugating enzyme, RAD6, affects the distribution of Ty1 retrotransposon integration positions. Genetics (1993) 1.47
Genetic interaction of RAD53 protein kinase with histones is important for DNA replication. Cell Cycle (2010) 1.40
Cell cycle-dependent localization of macroH2A in chromatin of the inactive X chromosome. J Cell Biol (2002) 1.36
Lys6-modified ubiquitin inhibits ubiquitin-dependent protein degradation. J Biol Chem (2005) 1.26
The proteasome: a macromolecular assembly designed for controlled proteolysis. Philos Trans R Soc Lond B Biol Sci (1999) 1.16
E3 ligases determine ubiquitination site and conjugate type by enforcing specificity on E2 enzymes. J Biol Chem (2011) 0.97
Host genes that affect the target-site distribution of the yeast retrotransposon Ty1. Genetics (1999) 0.93
The fission yeast ubiquitin-conjugating enzymes UbcP3, Ubc15, and Rhp6 affect transcriptional silencing of the mating-type region. Eukaryot Cell (2002) 0.89
Two ubiquitin-conjugating enzymes, Rhp6 and UbcX, regulate heterochromatin silencing in Schizosaccharomyces pombe. Mol Cell Biol (2002) 0.86
Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science (1986) 15.84
Recognition of the polyubiquitin proteolytic signal. EMBO J (2000) 10.12
A 26 S protease subunit that binds ubiquitin conjugates. J Biol Chem (1994) 4.93
The physician's actions and the outcome of illness in family practice. J Fam Pract (1986) 4.41
MAD2 associates with the cyclosome/anaphase-promoting complex and inhibits its activity. Proc Natl Acad Sci U S A (1997) 3.42
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol (2007) 2.85
Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles. Cell (1982) 2.79
Purification of two high molecular weight proteases from rabbit reticulocyte lysate. J Biol Chem (1987) 2.54
Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting. Proc Natl Acad Sci U S A (1996) 2.50
Characterization of two polyubiquitin binding sites in the 26 S protease subunit 5a. J Biol Chem (1998) 2.47
Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med (2006) 2.43
Purification of an 11 S regulator of the multicatalytic protease. J Biol Chem (1992) 2.35
Identification of the long ubiquitin extension as ribosomal protein S27a. Nature (1989) 1.93
Multiple forms of the 20 S multicatalytic and the 26 S ubiquitin/ATP-dependent proteases from rabbit reticulocyte lysate. J Biol Chem (1992) 1.81
Modification of the system of screening for antisyphilis antibodies in a blood transfusion centre, featuring a miniaturisation of the Treponema pallidum haemagglutination assay. J Clin Pathol (1982) 1.77
Ubiquitin-lysozyme conjugates. Identification and characterization of an ATP-dependent protease from rabbit reticulocyte lysates. J Biol Chem (1986) 1.70
The hydrophobic effect contributes to polyubiquitin chain recognition. Biochemistry (1998) 1.68
Subunit 4 of the 26 S protease is a member of a novel eukaryotic ATPase family. J Biol Chem (1992) 1.63
Arabidopsis MBP1 gene encodes a conserved ubiquitin recognition component of the 26S proteasome. Proc Natl Acad Sci U S A (1996) 1.58
Structure of the proteasome activator REGalpha (PA28alpha). Nature (1997) 1.56
Identification of an activation region in the proteasome activator REGalpha. Proc Natl Acad Sci U S A (1998) 1.54
Microinjection of ubiquitin: changes in protein degradation in HeLa cells subjected to heat-shock. J Cell Biol (1987) 1.52
Proteasome activator 11S REG or PA28: recombinant REG alpha/REG beta hetero-oligomers are heptamers. Biochemistry (1999) 1.49
Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators. J Biol Chem (1997) 1.47
Conjugation of ubiquitin to denatured hemoglobin is proportional to the rate of hemoglobin degradation in HeLa cells. Proc Natl Acad Sci U S A (1982) 1.44
The C terminus of mouse ornithine decarboxylase confers rapid degradation on dihydrofolate reductase. Support for the pest hypothesis. J Biol Chem (1991) 1.44
Microinjection of the nonhistone chromosomal protein HMG1 into bovine fibroblasts and HeLa cells. Cell (1979) 1.43
Ubiquitin-lysozyme conjugates. Purification and susceptibility to proteolysis. J Biol Chem (1986) 1.42
KEKE motifs. Proposed roles in protein-protein association and presentation of peptides by MHC class I receptors. FEBS Lett (1994) 1.37
Fluctuations in autonomic nervous activity during sleep displayed by power spectrum analysis of heart rate variability. Neurology (1995) 1.35
Degradation of microinjected proteins: effects of lysosomotropic agents and inhibitors of autophagy. J Cell Physiol (1983) 1.32
Degradation of proteins microinjected into cultured mammalian cells. J Cell Physiol (1979) 1.32
Inhibition of ubiquitin-mediated proteolysis by the Arabidopsis 26 S protease subunit S5a. J Biol Chem (1995) 1.25
Peptide sequencing identifies MSS1, a modulator of HIV Tat-mediated transactivation, as subunit 7 of the 26 S protease. FEBS Lett (1993) 1.24
Ubiquitin metabolism in cycling Xenopus egg extracts. J Biol Chem (1993) 1.22
Specific interactions between ATPase subunits of the 26 S protease. J Biol Chem (1997) 1.21
Mapping subunit contacts in the regulatory complex of the 26 S proteasome. S2 and S5b form a tetramer with ATPase subunits S4 and S7. J Biol Chem (2000) 1.20
Substrate specificity of the human proteasome. Chem Biol (2001) 1.19
Nucleotidase activities of the 26 S proteasome and its regulatory complex. J Biol Chem (1996) 1.18
Molecular cloning and expression of a gamma-interferon-inducible activator of the multicatalytic protease. J Biol Chem (1994) 1.16
Microinjection of ubiquitin: intracellular distribution and metabolism in HeLa cells maintained under normal physiological conditions. J Cell Biol (1987) 1.13
Functional characterization of the ubiquitin variant encoded by the baculovirus Autographa californica. Biochemistry (1996) 1.12
The selective degradation of injected proteins occurs principally in the cytosol rather than in lysosomes. Cell (1981) 1.11
The pyridine nucleotide cycle. Studies in Escherichia coli and the human cell line D98/AH2. J Biol Chem (1981) 1.11
Effects of temperature on the degradation of proteins in rabbit reticulocyte lysates and after injection into HeLa cells. Proc Natl Acad Sci U S A (1984) 1.11
Red cell-mediated microinjection. Natl Cancer Inst Monogr (1978) 1.11
Subunits of the regulatory complex of the 26S protease. Mol Biol Rep (1995) 1.09
Intracellular distribution and degradation of immunoglobulin G and immunoglobulin G fragments injected into HeLa cells. J Cell Biol (1983) 1.07
Molecular dissection of the 11S REG (PA28) proteasome activators. Biochimie (2001) 1.06
Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma. J Clin Oncol (2000) 1.04
Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and beta. EMBO J (2001) 1.02
Syphilis screening in the Blood Transfusion Service: a report of four years' experience with the Treponema pallidum haemagglutination assay and the subsequent development of a rapid "spin" method. J Clin Pathol (1987) 1.00
Molecular cloning and expression of a multiubiquitin chain binding subunit of the human 26S protease. FEBS Lett (1996) 0.98
Highly purified CD38+ and CD38- sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin. Leukemia (2007) 0.98
Extended reading frame of a ubiquitin gene encodes a stable, conserved, basic protein. J Biol Chem (1988) 0.98
Magnitude and significance of NAD turnover in human cell line D98/AH2. Nature (1976) 0.98
FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells. Br J Haematol (1999) 0.97
Synthesis of peptides as cloned ubiquitin extensions. J Biol Chem (1989) 0.96
The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells. Blood (2000) 0.95
Effects of interferon gamma and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases. Proc Natl Acad Sci U S A (1995) 0.95
Ubiquitination of full-length cyclin. FEBS Lett (1995) 0.94
Radiobiological evaluation of immigrants from the vicinity of Chernobyl. Int J Radiat Biol (1997) 0.94
Molecular cloning and expression of a 26 S protease subunit enriched in dileucine repeats. J Biol Chem (1995) 0.94
Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study. Br J Obstet Gynaecol (1999) 0.93
Activation of the multicatalytic protease. The 11 S regulator and 20 S ATPase complexes contain distinct 30-kilodalton subunits. J Biol Chem (1994) 0.93
Molecular cloning and expression of subunit 12: a non-MCP and non-ATPase subunit of the 26 S protease. FEBS Lett (1995) 0.93
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma. Br J Haematol (2001) 0.92
The biosynthesis and turnover of nicotinamide adenine dinucleotide in enucleated culture cells. J Cell Physiol (1974) 0.91
The N terminus of antizyme promotes degradation of heterologous proteins. J Biol Chem (1996) 0.90
Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression. Br J Haematol (1999) 0.89
B-lymphocyte suppression in multiple myeloma is a reversible phenomenon specific to normal B-cell progenitors and plasma cell precursors. Br J Haematol (1998) 0.88
The turnover of tRNAs microinjected into animal cells. Nucleic Acids Res (1978) 0.87
Identification, molecular cloning, and characterization of subunit 11 of the human 26S proteasome. FEBS Lett (1999) 0.86
Variant IRF4/MUM1 associates with CD38 status and treatment-free survival in chronic lymphocytic leukaemia. Leukemia (2010) 0.86
Proteolysis in heat-stressed HeLa cells. Stabilization of ubiquitin correlates with the loss of proline endopeptidase. J Biol Chem (1989) 0.86
The proteasome activator 11 S REG or PA28: chimeras implicate carboxyl-terminal sequences in oligomerization and proteasome binding but not in the activation of specific proteasome catalytic subunits. J Mol Biol (2000) 0.86
A proteasome activator subunit binds calcium. J Biol Chem (1995) 0.86
Comparative studies on microinjected high-mobility-group chromosomal proteins, HMG1 and HMG2. J Cell Biol (1981) 0.86
Assembly of the regulatory complex of the 26S proteasome. Mol Biol Rep (1999) 0.85
Tat-binding protein 7 is a subunit of the 26S protease. Biol Chem Hoppe Seyler (1994) 0.85
Arginine-rich histones do not exchange between human and mouse chromosomes in hybrid cells. Cell (1980) 0.85
Ubiquitin metabolism in ts85 cells, a mouse carcinoma line that contains a thermolabile ubiquitin activating enzyme. J Biol Chem (1990) 0.85
Kinetics of human chromosome loss from 3T3-human hybrid cells. Somatic Cell Genet (1978) 0.85
VATS resection of a mediastinal neurogenic dumbbell tumor. Surg Laparosc Endosc (1995) 0.85
Ubiquitin metabolism in HeLa cells starved of amino acids. FEBS Lett (1992) 0.85
Degradation of structurally characterized proteins injected into HeLa cells. Comparison with their stability in rabbit reticulocyte lysate. J Biol Chem (1989) 0.85
Turnover at nicotinamide adenine dinucleotide in cultures of human cells. J Cell Physiol (1976) 0.84
Osmotic lysis of pinosomes. Methods Enzymol (1987) 0.84
Pyridine nucleotide metabolism in mitotic cells. J Cell Physiol (1975) 0.84